“…Currently, several series have established a high degree of safety and efficacy of ONYX used intra-arterially and intra-venously in the treatment of intracranial DAVFs (1,6,9,29,31,32,40). The complete obliteration rate in arterial ONYX embolization was 61.3%-91.6% (22, [31][32][33]40) and that in venous ONYX embolization was 100% (21,23).…”